Clinical Trials ReportProgress and pitfalls with IBD serologies

被引：0
|
作者：
Joseph H. Sellin
机构：
来源：
Current Gastroenterology Reports | 2006年 / 8卷 / 5期
关键词：
Ulcerative Colitis; Capsule Endoscopy; Saccharo; Unaffected Relative; Outer Membrane Porin;
D O I：
10.1007/s11894-006-0018-4
中图分类号：
学科分类号：
摘要：
Anti-OMPC may be a familial trait in CD. This finding reflects a general but not entirely consistent body of literature indicating that IBD serologic patterns may run in families. This implies that anti-OMPC may serve as an immunologic risk marker for IBD and may represent a genetic susceptibility for CD. If genetically determined immunophenotypes are found to lead to IBD, an important insight into the etiology and pathophysiology of the disease may follow.
引用
收藏
页码：351 / 352
页数：1
相关论文
共 50 条
  • [31] Progresses and Pitfalls of Epigenetics in Solid Tumors Clinical Trials
    Rossi, Alice
    Zacchi, Francesca
    Reni, Anna
    Rota, Michele
    Palmerio, Silvia
    Menis, Jessica
    Zivi, Andrea
    Milleri, Stefano
    Milella, Michele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [32] Design and analysis of clinical trials in transplantation: Principles and pitfalls
    Schold, J. D.
    Kaplan, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (09) : 1779 - 1785
  • [33] Meta-analysis of clinical trials: uses and pitfalls
    Boissel, Jean-Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2007, 191 (4-5): : 759 - 770
  • [34] PITFALLS IN THE DESIGN OF CLINICAL-TRIALS WITH COGNITIVE ENHANCERS
    LOPEZIBOR, JJ
    NEUROPSYCHOPHARMACOLOGY, 1993, 9 (02) : S16 - S17
  • [35] POSITIVE GLUTEN SENSITIVITY SEROLOGIES AND THE IMPACT OF GLUTEN FREE DIET IN PATIENTS WITH IBD
    Dahar, Maria M.
    Rivers, Claudia Ramos
    Koutroumpakis, Filippos
    Ahsan, Maaz
    Dueker, Jeffrey
    Johnston, Elyse
    Barrie, Arthur
    Harrison, Janet
    Schwartz, Marc
    Hashash, Jana
    Babichenko, Dmitriy
    Tang, Gong
    Binion, David G.
    GASTROENTEROLOGY, 2021, 160 (06) : S55 - S55
  • [36] Innovations to improve the efficiency of phase II IBD clinical trials
    Nurulamin M. Noor
    Tim Raine
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 555 - 556
  • [37] TRENDS AND CHARACTERISTICS OF CLINICAL TRIALS PARTICIPATION IN THE IBD PARTNERS COHORT
    Johnson, Cole
    Barnes, Edward
    Zhang, Xian
    Long, Millie
    GASTROENTEROLOGY, 2020, 158 (03) : S18 - S19
  • [38] TRENDS AND CHARACTERISTICS OF CLINICAL TRIALS PARTICIPATION IN THE IBD PARTNERS COHORT
    Johnson, Cole
    Barnes, Edward
    Zhang, Xian
    Long, Millie
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S11 - S11
  • [39] Innovations to improve the efficiency of phase II IBD clinical trials
    Noor, Nurulamin M.
    Raine, Tim
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (09) : 555 - 556
  • [40] Analyzing the Racial Diversity of Clinical Trials in IBD: A Systematic Review
    Garcia, Alexander
    Singh, Avneet
    Jover, Queenzy
    Abidi, Zehara
    Shakeel, Aleeza
    Thakkar, Anand
    Hunter, Krystal
    Morales, Stephanie Rivera
    Contino, Krysta
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S844 - S845
12345